LATEST ONCOPRESCRIBE UPDATES
New ASCO Guideline Recommends Germline Testing in ALL Newly Diagnosed Breast Cancer Patients 65 Years or Younger
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
FDA Approves ALECENSA® as Adjuvant Treatment for ALK-Positive Non Small Cell Lung Cancer
Long Term Benefits of RUBRACA® Maintenance in Newly Diagnosed Ovarian Cancer
Omitting Axillary Lymph Node Dissection in Breast Cancer with Sentinel-Node Metastases
FDA Approves ENHERTU® for Unresectable or Metastatic HER2-Positive Solid Tumors
April 2024: Current Tumor-Agnostic Therapies
Enfortumab Vedotin plus Pembrolizumab: A Breakthrough in Locally Advanced or Metastatic Urothelial Carcinoma